The size of the pharmaceutical filtration market in Europe was worth USD 5.02 billion in 2022. It is further estimated to be growing at a CAGR of 8.7% and worth USD 7.62 billion by 2027.
Filtration is the process that helps separate suspended particles from a medium by passing them through a membrane. It is a physical technique employed in various fields, including the pharmaceutical industry. It is one of the essential processes adopted in the pharmaceutical industry.
Factors such as technological improvements, the presence of numerous major companies, and the rise in the manufacture of generic pharmaceuticals and biopharmaceutical and biopharmaceutical products are helping the pharmaceutical filtration market in Europe register a healthy growth rate during the forecast period. In addition, technological advancements in nanofiltration technology, an increase in demand for single-use technologies, an increase in healthcare research and development expenditure, and an increase in the number of pharmaceutical companies are further propelling the market growth.
Furthermore, the European pharmaceutical filtration market is predicted to expand due to the prevalence of chronic diseases, strong biological pipeline products, and increased demand for filters in the pharmaceutical and biopharmaceutical industries. Pharmaceutical filters with low operating pressure, high speed, and low energy consumption also drive market growth. Furthermore, increased product sales in a specific market and increased demand for pharmaceutical filtration in developing countries offer attractive opportunities for market participants.
However, high capital requirements and stringent government regulations impede the European filtration market growth.
This research report on the European pharmaceutical filtration market has been segmented and sub-segmented into the following categories:
The European pharmaceutical filtration market is expected to grow rapidly during the forecast period. The regional market growth is attributed to increased airborne infections, rising generics production, and growing technical improvements. As a result, the European pharmaceutical filtration market expansion in Europe is expanded by the countries such as the United Kingdom, Germany, France, Russia, and Italy.
The UK pharmaceutical filtration market dominated the European market in 2020, and it is anticipated to witness a prominent share during the forecast period. The market growth is projected to be fueled by the availability of advanced healthcare infrastructure, manufacturing centers, and favorable government policies. In addition, the pharmaceutical industry in the United Kingdom places a high value on research and development. Furthermore, the government industrial policy intends to persuade universities and small, medium, and large businesses to interact to increase investment, which is expected to promote the market’s growth.
On the other hand, the German pharmaceutical filtration market is more likely to showcase a significant share in Europe during the forecast period. Development of existing research and development sits for domestic and international multinationals is covered in Germany. The region is often regarded as the top international site for developing, researching, and distributing high-quality pharmaceuticals. Direct access to internationally famous scientists, large pharmaceutical markets, and outstanding research units is another component that contributes to this aspect.
Furthermore, France's European pharmaceutical filtration market is expected to benefit from the massive manufacturing of active pharmaceutical ingredients (API) by pharma giants. France is one of the largest buyers of pharmaceutical products. It’s also one of the most challenging markets to break into for pharmaceuticals. Growing demand for medications, advances in medical biotechnology research, and increasing healthcare spending are expected to boost France’s market growth.
KEY MARKET PLAYERS:
Companies playing an influential role in the European pharmaceutical filtration market profiled in the Report are Merck KGaA, Pall Corporation, GE Healthcare, 3M Company, Parker Hannifin Corporation, Sartorius Stedim Biotech S.A., Eaton Corporation PLC, Graver Technologies, LLC, Amazon Filters Ltd., and Meissner Filtration Products, Inc.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com